Abstract
CORRELATION BETWEEN TREATMENT OF RHEUMATOID ARTHRITIS USING NON BIOLOGICAL DMARDS AND DISEASE ACTIVITY USING RAPID-3 SCALE

Dr. Chitrak Bansal*, Dr. Prithpal Singh Matreja and Dr. Najmul Huda

ABSTRACT

Rheumatoid Arthritis (RA) is a chronic inflammatory autoimmune disorder which results in destruction of joints with increased morbidity and mortality. Due to requirement of prolonged therapy it is need of hour to evaluate the correlation between RAPID-3 (Routine Assessment of Patient Index Data 3) and disease activity among patients treated for RA using non-biological disease modifying anti rheumatoid drugs. Hence this randomized cross sectional study was planned to done among patients attending Orthopaedic OPD, found suitable after applying inclusion and exclusion criteria. Patients were divided into 5 groups on the basis of drugs prescribed to them. Group A was prescribed with Methotrexate, Hydrxychloroquine, Deflazacort and Piroxicam. Group B was prescribed with Methotrexate, Salfasalazine, Deflazacort and Piroxicam. Group C was prescribed with Methotrexate, Hydroxychloroquine and Piroxicam. Group D was prescribed with Methotrexate Salfasalazine and Aceclofenac and Group E was prescribed with Methotrexate, Hydroxychloroquine and Aceclofenac. RAPID-3 score of patients at day 0 and after 60 days of treatment were noted and evaluation was done for correlation and efficacy of treatment. In our study this was observed that (n=08) patients of Group A had shown the most efficacy towards treatment of RA which was reflected by significant decrease in mean RAPID-3 score of these patients after 60 days of treatment. Our study indicates that RAPID-3 scoring system can used as a reliable tool for quick assessment of disease activity and efficacy of treatment in a busy clinical environment.

Keywords: Rheumatoid Arthritis, RAPID-3, Disease Modifying Anti-Rheumatoid Drugs.


[Full Text Article]   [Download Certificate]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: MARCH ISSUE PUBLISHED

    MARCH 2024 Issue has been successfully launched on 1 MARCH 2024.

  • EJBPS New Impact Factor

    EJBPS Impact Factor has been Increased to 7.482 for Year 2024.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT